Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges? Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies

被引:1
|
作者
Stemler, Jannik [1 ,2 ,3 ,4 ,5 ,6 ]
Cornely, Oliver A. [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
机构
[1] Univ Cologne, Fac Med, Cologne, Germany
[2] Univ Cologne, Univ Hosp Cologne, Cologne Excellence Cluster Cellular Stress Respons, Translat Res, Cologne, Germany
[3] Univ Cologne, Ctr Integrated Oncol Aachen Bonn Cologne Duesseldo, Departmentof Internal Med 1, Cologne, Germany
[4] Univ Cologne, Fac Med, Excellence Ctr Med Mycol ECMM, Cologne, Germany
[5] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[6] German Ctr Infect Res DZIF, Partner Site Bonn-Cologne, Cologne, Germany
[7] Univ Cologne, Univ Hosp Cologne, Clin Trials Ctr Cologne ZKS Koln, Cologne, Germany
来源
HEMASPHERE | 2022年 / 6卷 / 07期
关键词
QUALITY-OF-LIFE; MULTIPLE-MYELOMA; TREATMENT PATTERNS; POPULATION; CANCER;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [2] EHA guideline: antifungal prophylaxis in acute myeloid leukemia treated with novel agents
    Stemler, J.
    Skoetz, N.
    de Jonge, N.
    Bruggemann, R.
    Sinko, J.
    Busca, A.
    Ben Ami, R.
    Racil, Z.
    Piechotta, V.
    Lewis, R.
    Cornely, O. A.
    MYCOSES, 2021, 64 : 3 - 4
  • [3] Challenges and considerations for antifungal prophylaxis in children with acute myeloid leukemia
    Yeoh, Daniel K.
    Haeusler, Gabrielle M.
    Slavin, Monica A.
    Kotecha, Rishi S.
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (10) : 679 - 686
  • [4] Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma
    Stemler, Jannik
    Koehler, Philipp
    Maurer, Christian
    Mueller, Carsten
    Cornely, Oliver A.
    ANNALS OF HEMATOLOGY, 2020, 99 (07) : 1429 - 1440
  • [5] Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma
    Jannik Stemler
    Philipp Koehler
    Christian Maurer
    Carsten Müller
    Oliver A. Cornely
    Annals of Hematology, 2020, 99 : 1429 - 1440
  • [6] Isavuconazonium or posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia
    White, Olivia
    Kennedy, Erin
    Huckabee, Jordan B. B.
    Rogers, Elizabeth
    LeBlanc, Thomas W. W.
    Dillon, Mairead
    Li, Zhiguo
    Hanna, Desirae
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (03) : 527 - 534
  • [7] Micafungin as primary antifungal prophylaxis in patients presenting with acute myeloid leukemia
    Venton, G.
    Adam, H.
    Colle, J.
    Labiad, Y.
    Mercier, C.
    Ivanov, V.
    Suchon, P.
    Fanciullino, R.
    Farnault, L.
    Costello, R.
    MEDECINE ET MALADIES INFECTIEUSES, 2016, 46 (04): : 226 - 229
  • [8] Should patients with acute myeloid leukemia treated with venetoclax-based regimens receive antifungal prophylaxis?
    Guarana, Mariana
    Nucci, Marcio
    LEUKEMIA RESEARCH, 2023, 131
  • [9] Management of patients with acute myeloid leukemia undergoing therapy with midostaurin: a focus on antifungal prophylaxis
    Cairoli, Roberto
    Ferrara, Felicetto
    Girmenia, Corrado
    Luppi, Mario
    Pea, Federico
    Specchia, Giorgina
    Venditti, Adriano
    HEMATOLOGICAL ONCOLOGY, 2021, 39 (01) : 20 - 26
  • [10] Incidence of Invasive Fungal Infections in Acute Myeloid Leukemia Without Antifungal Prophylaxis
    Signorelli, Jessie
    Lei, Matthew
    Lam, Jenna
    Jalbut, Marla
    Amrein, Philip C.
    Fathi, Amir T.
    Hobbs, Gabriela
    Hock, Hanno
    McAfee, Steven Lawrence
    Letourneau, Alyssa R.
    Narayan, Rupa
    Brunner, Andrew
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (11): : E883 - E889